849 related articles for article (PubMed ID: 25622756)
21. Involvement of a novel Rac/RhoA guanosine triphosphatase-nuclear factor-kappaB inducing kinase signaling pathway mediating angiotensin II-induced RelA transactivation.
Choudhary S; Lu M; Cui R; Brasier AR
Mol Endocrinol; 2007 Sep; 21(9):2203-17. PubMed ID: 17595324
[TBL] [Abstract][Full Text] [Related]
22. Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcome.
Tran NL; McDonough WS; Savitch BA; Fortin SP; Winkles JA; Symons M; Nakada M; Cunliffe HE; Hostetter G; Hoelzinger DB; Rennert JL; Michaelson JS; Burkly LC; Lipinski CA; Loftus JC; Mariani L; Berens ME
Cancer Res; 2006 Oct; 66(19):9535-42. PubMed ID: 17018610
[TBL] [Abstract][Full Text] [Related]
23. NF-kappaB inducing kinase activates NF-kappaB transcriptional activity independently of IkappaB kinase gamma through a p38 MAPK-dependent RelA phosphorylation pathway.
Jijon H; Allard B; Jobin C
Cell Signal; 2004 Sep; 16(9):1023-32. PubMed ID: 15212763
[TBL] [Abstract][Full Text] [Related]
24. TWEAK favors phosphate-induced calcification of vascular smooth muscle cells through canonical and non-canonical activation of NFκB.
Hénaut L; Sanz AB; Martin-Sanchez D; Carrasco S; Villa-Bellosta R; Aldamiz-Echevarria G; Massy ZA; Sanchez-Nino MD; Ortiz A
Cell Death Dis; 2016 Jul; 7(7):e2305. PubMed ID: 27441657
[TBL] [Abstract][Full Text] [Related]
25. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
Tran NL; McDonough WS; Savitch BA; Sawyer TF; Winkles JA; Berens ME
J Biol Chem; 2005 Feb; 280(5):3483-92. PubMed ID: 15611130
[TBL] [Abstract][Full Text] [Related]
26. Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase.
Ramakrishnan P; Wang W; Wallach D
Immunity; 2004 Oct; 21(4):477-89. PubMed ID: 15485626
[TBL] [Abstract][Full Text] [Related]
27. TNFα induced noncanonical NF-κB activation is attenuated by RIP1 through stabilization of TRAF2.
Kim JY; Morgan M; Kim DG; Lee JY; Bai L; Lin Y; Liu ZG; Kim YS
J Cell Sci; 2011 Feb; 124(Pt 4):647-56. PubMed ID: 21266470
[TBL] [Abstract][Full Text] [Related]
28. TWEAK promotes ovarian cancer cell metastasis via NF-kappaB pathway activation and VEGF expression.
Dai L; Gu L; Ding C; Qiu L; Di W
Cancer Lett; 2009 Oct; 283(2):159-67. PubMed ID: 19398263
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of NF-κB inducing kinase underlies constitutive NF-κB activation in lung cancer cells.
Saitoh Y; Martínez Bruyn VJ; Uota S; Hasegawa A; Yamamoto N; Imoto I; Inazawa J; Yamaoka S
Lung Cancer; 2010 Dec; 70(3):263-70. PubMed ID: 20338663
[TBL] [Abstract][Full Text] [Related]
30. The Src homology 3 domain-containing guanine nucleotide exchange factor is overexpressed in high-grade gliomas and promotes tumor necrosis factor-like weak inducer of apoptosis-fibroblast growth factor-inducible 14-induced cell migration and invasion via tumor necrosis factor receptor-associated factor 2.
Fortin Ensign SP; Mathews IT; Eschbacher JM; Loftus JC; Symons MH; Tran NL
J Biol Chem; 2013 Jul; 288(30):21887-97. PubMed ID: 23775076
[TBL] [Abstract][Full Text] [Related]
31. The noncanonical NF-κB pathway.
Sun SC
Immunol Rev; 2012 Mar; 246(1):125-40. PubMed ID: 22435551
[TBL] [Abstract][Full Text] [Related]
32. B-cell CLL/lymphoma 10 (BCL10) is required for NF-kappaB production by both canonical and noncanonical pathways and for NF-kappaB-inducing kinase (NIK) phosphorylation.
Bhattacharyya S; Borthakur A; Tyagi S; Gill R; Chen ML; Dudeja PK; Tobacman JK
J Biol Chem; 2010 Jan; 285(1):522-30. PubMed ID: 19897484
[TBL] [Abstract][Full Text] [Related]
33. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling.
Kanno Y; Sakurai D; Hase H; Kojima H; Kobata T
J Recept Signal Transduct Res; 2010 Apr; 30(2):121-32. PubMed ID: 20184394
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor-like weak inducer of apoptosis stimulation of glioma cell survival is dependent on Akt2 function.
Fortin SP; Ennis MJ; Savitch BA; Carpentieri D; McDonough WS; Winkles JA; Loftus JC; Kingsley C; Hostetter G; Tran NL
Mol Cancer Res; 2009 Nov; 7(11):1871-81. PubMed ID: 19861406
[TBL] [Abstract][Full Text] [Related]
35. Lipopolysaccharide-induced activation of NF-κB non-canonical pathway requires BCL10 serine 138 and NIK phosphorylations.
Bhattacharyya S; Borthakur A; Dudeja PK; Tobacman JK
Exp Cell Res; 2010 Nov; 316(19):3317-27. PubMed ID: 20466000
[TBL] [Abstract][Full Text] [Related]
36. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation.
Liao G; Zhang M; Harhaj EW; Sun SC
J Biol Chem; 2004 Jun; 279(25):26243-50. PubMed ID: 15084608
[TBL] [Abstract][Full Text] [Related]
37. TNF-like weak inducer of apoptosis inhibits proinflammatory TNF receptor-1 signaling.
Wicovsky A; Salzmann S; Roos C; Ehrenschwender M; Rosenthal T; Siegmund D; Henkler F; Gohlke F; Kneitz C; Wajant H
Cell Death Differ; 2009 Nov; 16(11):1445-59. PubMed ID: 19557010
[TBL] [Abstract][Full Text] [Related]
38. Stabilization of basally translated NF-kappaB-inducing kinase (NIK) protein functions as a molecular switch of processing of NF-kappaB2 p100.
Qing G; Qu Z; Xiao G
J Biol Chem; 2005 Dec; 280(49):40578-82. PubMed ID: 16223731
[TBL] [Abstract][Full Text] [Related]
39. Nuclear factor κB-inducing kinase activation as a mechanism of pancreatic β cell failure in obesity.
Malle EK; Zammit NW; Walters SN; Koay YC; Wu J; Tan BM; Villanueva JE; Brink R; Loudovaris T; Cantley J; McAlpine SR; Hesselson D; Grey ST
J Exp Med; 2015 Jul; 212(8):1239-54. PubMed ID: 26122662
[TBL] [Abstract][Full Text] [Related]
40. Maximal adamantyl-substituted retinoid-related molecule-induced apoptosis requires NF-κB noncanonical and canonical pathway activation.
Farhana L; Dawson MI; Murshed F; Fontana JA
Cell Death Differ; 2011 Jan; 18(1):164-73. PubMed ID: 20671747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
